Form 8-K · Current report
BXP, Inc. 8-K, filed Aug 31, 2026
- Filed
- CIK
- 0001037540
- Accession no.
- 0001037540-26-000037
Summary
Boston Properties Limited Partnership, the operating partnership of BXP, Inc., completed the sale of $700.0 million of 6.050% senior notes due 2036, with estimated net proceeds of about $692.4 million. It intends to use the proceeds toward redeeming or repaying its $1.0 billion of 2.750% senior notes due 2026, with the remainder funded by available cash or borrowings under its unsecured revolving line of credit.
Key points
- The notes were issued under Supplemental Indenture No. 27 dated August 31, 2026.
- Net proceeds are estimated at approximately $692.4 million after underwriting discounts and estimated transaction expenses.
- The 2.750% senior notes due 2026 are scheduled to mature on October 1, 2026.
- The underwriters were represented by J.P. Morgan Securities LLC, BBVA Securities Inc., BNY Mellon Capital Markets, LLC, PNC Capital Markets LLC, TD Securities (USA) LLC, U.S. Bancorp Investments, Inc., and Wells Fargo Securities, LLC.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01. Other Events. On August 31, 2026, Boston Properties Limited Partnership (the “Partnership”), the operating partnership of BXP, Inc. (the “Company”), completed the issuance and sale of $700.0 million aggregate principal amount of the Partnership’s 6.050% Senior Notes due 2036 (the “Notes”) pursuant to an underwriting agreement, dated August 17, 2026 (the “Underwriting Agreement”), by and among the Partnership and J.P. Morgan Securities LLC, BBVA Securities Inc., BNY Mellon Capital Markets, LLC, PNC Capital Markets LLC, TD Securities (USA) LLC, U.S. Bancorp Investments, Inc. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.